ArticleFrontiers in immunology2024
Prediction of the risk of mortality in older patients with coronavirus disease 2019 using blood markers and machine learning.
Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mitigating bias in AI mortality predictions for minority populations: a transfer learning approach.BMC medical informatics and decision making · 2025Article
- Simplified flow cytometry-based assay for rapid multi-cytokine profiling and machine-learning-assisted diagnosis of inflammatory diseases.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The mortality rate among older people infected with severe acute respiratory syndrome coronavirus 2 is alarmingly high. This study aimed to explore the predictive value of a novel model for assessing the risk of death in this vulnerable cohort. Methods: We enrolled 199 older patients with coronavirus disease 2019 (COVID-19) from Zhejiang Provincial Hospital of Chinese Medicine (Hubin) between 16 December 2022 and 17 January 2023. Additionally, 90 patients from two other centers (Qiantang and Xixi) formed an external independent testing cohort. Univariate and multivariate analyses were used to identify the risk factors for mortality. Least absolute shrinkage and selection operator (LASSO) regression analysis was used to select variables associated with COVID-19 mortality. Nine machine-learning algorithms were used to predict mortality risk in older patients, and their performance was assessed using receiver operating characteristic curves, area under the curve (AUC), calibration curve analysis, and decision curve analysis. Results: Neutrophil-monocyte ratio, neutrophil-lymphocyte ratio, C- reactive protein, interleukin 6, and D-dimer were considered to be relevant factors associated with the death risk of COVID-19-related death by LASSO regression. The Gaussian naive Bayes model was the best-performing model. In the validation cohort, the model had an AUC of 0.901, whereas in the testing cohort, the model had an AUC of 0.952. The calibration curve showed a good correlation between the actual and predicted probabilities, and the decision curve indicated a strong clinical benefit. Furthermore, the model had an AUC of 0.873 in an external independent testing cohort. Discussion: In this study, a predictive machine-learning model was developed with an online prediction tool designed to assist clinicians in evaluating mortality risk factors and devising targeted and effective treatments for older patients with COVID-19, potentially reducing the mortality rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.